Holen Sie sich die Stockscreener-App
3.88
5.43%
0.20
Handel nachbörslich:
3.88
Schlusskurs vom Vortag:
$3.68
Offen:
$3.68
24-Stunden-Volumen:
791.40K
Relative Volume:
1.03
Marktkapitalisierung:
$215.22M
Einnahmen:
$163.78M
Nettoeinkommen (Verlust:
$25.88M
KGV:
5.9692
EPS:
0.65
Netto-Cashflow:
$-28.66M
1W Leistung:
+14.12%
1M Leistung:
+20.87%
6M Leistung:
-2.02%
1J Leistung:
-37.42%
1-Tages-Spanne:
$3.58
$3.92
1-Wochen-Bereich:
$3.32
$3.92
52-Wochen-Spanne:
$2.645
$8.275
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Firmenname
Voyager Therapeutics Inc
Sektor
Branche
Telefon
857-259-5340
Adresse
75 HAYDEN AVENUE, LEXINGTON, MA
Vergleichen Sie VYGR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
3.88 | 198.58M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Eingeleitet | Citigroup | Buy |
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-10-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-03-26 | Eingeleitet | Guggenheim | Buy |
| 2024-03-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-07 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Eingeleitet | Truist | Buy |
| 2023-03-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-02-03 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-12-24 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-15 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-09-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-12 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-02-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-11-28 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-23 | Bestätigt | Stifel | Buy |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-28 | Fortgesetzt | Stifel | Buy |
Alle ansehen
Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten
Best data tools to analyze Voyager Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - Newser
Voyager Therapeutics Inc. stock daily chart insightsTrade Signal Summary & Entry Point Strategy Guides - Newser
How to escape a deep drawdown in Voyager Therapeutics Inc.Market Performance Summary & Fast Exit and Entry Trade Guides - Newser
Published on: 2025-09-03 05:39:51 - Newser
Volume spikes in Voyager Therapeutics Inc. stock – what they meanBull Run & Weekly High Potential Stock Alerts - Newser
What’s next for Voyager Therapeutics Inc. stock priceRecession Risk & AI Based Buy and Sell Signals - Newser
Using Bollinger Bands to evaluate Voyager Therapeutics Inc.Portfolio Update Summary & Low Drawdown Trading Strategies - Newser
What data driven models say about Voyager Therapeutics Inc.’s future - Newser
Voyager Therapeutics Inc. stock trend forecastJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Detecting support and resistance levels for Voyager Therapeutics Inc.Earnings Risk Summary & Technical Buy Zone Confirmation - Newser
Technical signs of recovery in Voyager Therapeutics Inc.2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
Is Voyager Therapeutics Inc. stock influenced by commodity pricesM&A Rumor & Daily Profit Maximizing Tips - khodrobank.com
Can trapped investors hope for a rebound in Voyager Therapeutics Inc.July 2025 Levels & Verified Swing Trading Watchlist - Newser
Voyager Therapeutics: A High-Conviction Play in Neuro-Genetic Innovation - AInvest
Order Flow Trends Show Accumulation in Voyager Therapeutics Inc.Market Risk Summary & Verified Momentum Stock Ideas - beatles.ru
Voyager Therapeutics: Pioneering Non-Viral Delivery in Neurotherapeutics - AInvest
Regression analysis insights on Voyager Therapeutics Inc. performanceTrade Volume Report & Long-Term Safe Investment Ideas - Newser
Voyager Therapeutics’ Strategic Momentum in Neurological Disease Innovation: Assessing the Investment Potential of Preclinical Pipeline and Non-Viral Delivery Platform - AInvest
Voyager Therapeutics Presents at Citi's Biopharma Back to School Conference - AInvest
Transcript : Voyager Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-02-2025 04 - MarketScreener
What is the dividend yield of Voyager Therapeutics Inc.Quarterly Market Summary & Verified Momentum Stock Watchlist - khodrobank.com
Relative strength of Voyager Therapeutics Inc. in sector analysis2025 Historical Comparison & Growth Focused Investment Plans - Newser
Applying Wyckoff theory to Voyager Therapeutics Inc. stockEarnings Beat & High Conviction Buy Zone Picks - Newser
Is There Enough Volume to Lift Voyager Therapeutics Inc.Market Weekly Review & Low Risk High Win Rate Stock Picks - beatles.ru
Does Voyager Therapeutics Inc. stock benefit from AI growthPortfolio Risk Summary & Verified Momentum Stock Watchlist - khodrobank.com
Can Voyager Therapeutics Inc. be recession proofWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - khodrobank.com
Analyzing drawdowns of Voyager Therapeutics Inc. with statistical toolsMarket Activity Summary & Consistent Income Trade Recommendations - Newser
Published on: 2025-09-01 14:05:37 - Newser
Earnings visualization tools for Voyager Therapeutics Inc.2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Can Voyager Therapeutics Inc. rally from current levels2025 Top Decliners & Expert Approved Trade Ideas - Newser
Voyager Therapeutics Inc. stock outlook for YEARPortfolio Value Summary & Daily Stock Trend Watchlist - Newser
Trend analysis for Voyager Therapeutics Inc. this weekEarnings Beat & Community Supported Trade Ideas - Newser
Using Bollinger Bands to evaluate Voyager Therapeutics IncJuly 2025 Breakouts & Weekly High Potential Stock Alerts - Newser
Price Channel Expanding on Voyager Therapeutics Inc.’s ChartWeekly Profit Report & Daily Growth Stock Tips - beatles.ru
Voyager Therapeutics Inc. Testing Reversal Zone on Weekly Chart getLinesFromResByArray error: size == 0 - thegnnews.com
RSI + MACD Show Convergence for Voyager Therapeutics Inc.2025 Momentum Check & AI Forecast Swing Trade Picks - beatles.ru
Is Voyager Therapeutics Inc. stock reversal real or fakeGap Down & Long-Term Capital Growth Strategies - Newser
Analyzing net buyer seller activity in Voyager Therapeutics Inc.July 2025 Summary & Technical Pattern Based Buy Signals - Newser
Using fundamentals and technicals on Voyager Therapeutics Inc.2025 Top Gainers & Reliable Price Breakout Signals - Newser
Price Clustering Detected in Voyager Therapeutics Inc. Stock getLinesFromResByArray error: size == 0 - 클래시안
Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):